Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
Go back to Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry| (NASDAQ: IMDX) | Delayed: 4.21 +0.08 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $ | |||
| Open | $4.13 | 52 Week Low | $ | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $ | |||
| Volume | 75,578 | |||||

